Mohamad Zamir Hussain

Mohamad Zamir Hussain

Active Director Director DIN 07276709
DIN 07276709 First appointment Oct 2015 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohamad Zamir Hussain

Data last updated:

Mohamad Zamir Hussain is a Director at Dr. Heal Pharmaceuticals Private Limited (since 2015). The company operates in Business Services.

DIN 07276709
Primary Designation Director
Industry Business Services
First Appointment 08 Oct 2015
Oldest Company Age 11 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Oct 20152015Active

Board colleagues of Mohamad Zamir Hussain

Directorship timeline

Open interactive timeline →
Dr. Heal Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mohamad Zamir Hussain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohamad Zamir Hussain

Mohamad Zamir Hussain currently holds 1 directorship: Dr. Heal Pharmaceuticals Private Limited (Director, since 08 Oct 2015).

Mohamad Zamir Hussain was first appointed on 08 Oct 2015 as Director at Dr. Heal Pharmaceuticals Private Limited.

The current boards of Mohamad Zamir Hussain's companies include Mashkoor Alam (Dr. Heal Pharmaceuticals Private Limited), Mohd Naushad Alam (Dr. Heal Pharmaceuticals Private Limited), Neyaz Ahmed (Dr. Heal Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available